Bruce Magun, Ph.D

Head Shot of Bruce Magun
click here


My major fields of interest involve cellular mechanisms of inflammatory signaling cascades that control the responses to environmental toxic agents.In some studies, the laboratory investigates how proinflammatory signals (cytokines, toxins, and other stressors) interact with surface receptors to activate the stress-activated protein kinases and NF-kappaB and how activation of these pathways leads to transcriptional regulation of genes. Some projects involve the effects of ricin, a potential bioterrorist agent, on activating proinflammatory pathways in vitro and in mouse models.In other studies we are investigating the mechanisms that control the responses keratinocytes to environmental agents such as ultraviolet radiation and xenobiotic toxic agents.

Selected Publications

"Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs: Synergistic effects of doxorubicin and vincristine," Cancer Biology and Therapy (Vol: 15, Issue: 10, Page 1395-1403) - 2014

"Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of Doxorubicin," Cancer Biology and Therapy (Vol: 14, Issue: 1, Page 56-63) - 2013

"Ricin and Shiga toxins: Effects on host cell Signal transduction," Current Topics in Microbiology and Immunology (Vol: 357, Page 41-65) - 2012

"Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinib.," Frontiers in cellular and infection microbiology (Vol: 2, Page 135-) - 2012

"Suppression of ribosomal function triggers innate immune signaling through activation of the NLRP3 inflammasome," PLoS ONE (Vol: 7, Issue: 5, ) - 2012



  Email Bruce Magun

503 494-7811

Memberships & Associations

Cell & Developmental Biology
Neuroscience Graduate Program
Program in Molecular & Cellular Biosciences
Cancer Biology